{
    "title": "Pfizer sees Covid-19 drug sales topping $50 bn in 2022",
    "url": "https://www.dailymail.co.uk/wires/afp/article-10490663/Pfizer-sees-Covid-19-drug-sales-topping-50-bn-2022.html",
    "date": "2022-02-08",
    "keywords": [
        "covid19",
        "vaccine",
        "pfizer",
        "company",
        "companys",
        "bourla",
        "treatment",
        "year",
        "paxlovid",
        "virus",
        "pandemic",
        "interest",
        "conover",
        "covid",
        "future",
        "tuesday",
        "giant",
        "innoculation",
        "vaccinee",
        "biontech",
        "infusion",
        "pill",
        "executive",
        "albert",
        "fourthquarter",
        "medicine",
        "inflammation",
        "immunology",
        "oncology",
        "disease",
        "level",
        "coronavirus",
        "amount",
        "forecast",
        "revenue",
        "candidate",
        "omicron",
        "variant",
        "nextgeneration",
        "quarter",
        "half",
        "contract",
        "world",
        "way",
        "estimate",
        "agreement",
        "officer",
        "frank",
        "damelio",
        "upside",
        "utilization",
        "demand",
        "term",
        "note",
        "market",
        "help",
        "phase",
        "percent"
    ],
    "category": [
        "wires",
        "afp"
    ]
}